XML 30 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net loss $ (90,733) $ (159,457) $ (156,079)
Adjustments to reconcile net loss to cash provided by (used in) operating activities      
Derecognition of the TRA liability 0 (122,515) 0
Depreciation and amortization 111,292 122,102 114,215
Equity-based compensation expense 10,621 13,825 15,978
Loss on asset write-off and retirements 0 71,942 29,881
Amortization of deferred financing costs 58 267 164
Deferred tax provision (benefit) (14,634) 15,543 (27,536)
Reversal of deferred tax assets associated with the TRA 0 46,874 0
Provision for bad debts 159 950 11,581
(Gain) loss on disposal of assets (1,309) (2,045) 1,117
Changes in fair value of investments 1,199 (2,627) (1,123)
Unrealized (gain) loss on derivative (386) 634 64
Realized loss on sale of investment 0 478 0
Other 843 (1,876) 0
Changes in operating assets and liabilities, net of effects from acquisitions      
Accounts receivable (63,654) 21,271 70,388
Inventories (2,917) 12,102 27,379
Other current assets 4,581 8,677 4,039
Other assets 258 674 (692)
Accounts payable and accrued liabilities 15,310 15,774 (47,068)
Deferred revenue (354) (13,373) (39,659)
Other noncurrent liabilities (2,978) (4,446) (13,480)
Net cash provided by (used in) operating activities (32,644) 24,774 (10,831)
Cash flows from investing activities      
Acquisition of Blackhawk (net of acquired cash) 0 0 (150,437)
Purchase of property, plant and equipment and intangibles (19,734) (21,990) (42,127)
Purchase of property, plant and equipment from related parties (36,737) 0 0
Proceeds from sale of assets and equipment 7,089 14,030 3,858
Purchase of investments (84,040) (123,048) (1,003)
Proceeds from sale of investments 143,825 53,299 11,101
Other 0 0 (307)
Net cash provided by (used in) investing activities 10,403 (77,709) (178,915)
Cash flows from financing activities      
Repayments of borrowings (5,892) (680) (7,201)
Proceeds from borrowings 0 0 363
Dividends paid on common stock 0 (50,154) (79,013)
Dividends paid on preferred stock 0 0 (1)
Deferred financing costs (1,733) 0 0
Cost of Series A convertible preferred stock conversion to common stock 0 0 (595)
Distribution to noncontrolling interest 0 0 (8,027)
Treasury shares withheld (1,636) (2,901) (3,264)
Proceeds from the issuance of ESPP shares 1,315 1,264 973
Net cash used in financing activities (7,946) (52,471) (96,765)
Effect of exchange rate changes on cash 3,384 (1,105) 3,678
Net decrease in cash (26,803) (106,511) (282,833)
Cash and cash equivalents at beginning of period 213,015 319,526 602,359
Cash and cash equivalents at end of period $ 186,212 $ 213,015 $ 319,526